BIOTREND
BIOTREND (Clinisciences) is a private B2B e-commerce distributor of scientific reagents, instruments, and custom cell-line services for immunology, cell biology, and molecular biology research laboratories worldwide.
- Company typePrivate
- Founded2002
- HeadquartersCologne, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BIOTREND does
BIOTREND operates a B2B e-commerce distribution platform for scientific reagents and instruments under the trade name Clinisciences. Founded in 2002, the company serves research laboratories and institutions conducting immunology, cell biology, and molecular biology work, offering a broad catalog that spans cell-based assays, IHC detection kits, FPLC columns, histological stains, immunoassays, lectins, NGS reagents, radiochemicals, plant tissue culture products, and tetramers/monomers. Its proprietary technology stack centers on the upcyte cell technology — a method for isolating primary cells from donor tissue and expanding them into error-free proliferating cells — which underpins its ixCyte custom cell line development service. The company also distributes the LymphoSign CE-IVD classified diagnostic workflow capable of classifying over 80 subtypes of Non-Hodgkin Lymphoma, and offers GMP-grade solutions and custom manufacturing of peptides, proteins, and antibodies.
The business model is primarily one-time sales of distributed reagents and instruments, supplemented by professional services revenue from custom manufacturing and cell line development. Pricing is quote-based and not publicly disclosed. Go-to-market is executed through a multi-language (seven languages) direct e-commerce storefront with account registration and shopping cart functionality, complemented by a network of worldwide offices and authorized distributors. The company reaches customers through email newsletters, social media (Facebook, LinkedIn), webinars, and participation in scientific conferences such as RBMP 2026 XVIII and ICB CDT Chemical. Customer relationships are anchored to technical partnerships with Upcyte (proprietary cell technology), Bioss (recombinant monoclonal antibodies), and LymphoSign (CE-IVD diagnostic workflow). The legal operating entity is Clinisciences, with a US presence registered in Miramar Beach, Florida, while the BIOTREND brand appears as a co-brand on company materials.
BIOTREND firmographics
Firmographics- Name
- BIOTREND
- Legal name
- Clinisciences
- Website
- https://biotrend.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BIOTREND (Clinisciences) is a private B2B e-commerce distributor of scientific reagents, instruments, and custom cell-line services for immunology, cell biology, and molecular biology research laboratories worldwide.
- Ownership category
- akta.pro rank
BIOTREND industry classification
Industry- Product category
- Life Sciences Research Reagents
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (4242), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)
- akta.pro secondary industry
- Biologics & Biosimilars Distributors (HLAIAJAH)
Keywords
Where BIOTREND is headquartered
LocationHeadquarters
- HQ city
- Cologne
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
BIOTREND business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Scientific reagent and instrument sales: Distribution and sale of reagents and instruments for immunology, cell biology, and molecular biology research through e-commerce platform. Products include cell-based assay kits, culture vessels, detection kits, FPLC columns, histological stains, immunoassays, lectins, NGS products, plant tissue culture products, radiochemicals, tetramers and monomers.
- Custom manufacturing services: Custom production of peptides, proteins and antibodies tailored to customer specifications. Also includes upcyte cell technology services and ixCyte cell line development.
Distribution channels2 records
Marketing channels4 records
BIOTREND product offering
Product offeringCore offering
BIOTREND (operating as Clinisciences) distributes a broad catalog of scientific reagents, kits, and instruments used by research laboratories in immunology, cell biology, and molecular biology. The company also provides custom manufacturing services for peptides, proteins, and antibodies, and distributes proprietary cell technology (upcyte/ixCyte) and CE-IVD diagnostic workflows (LymphoSign). Customers purchase through a B2B e-commerce storefront with account registration and shopping-cart checkout, with international fulfillment via worldwide offices and distributor partners.
Product overview
BIOTREND operates as a distributor offering a comprehensive portfolio of reagents and instruments for immunology, cell biology, and molecular biology research. The product portfolio includes cell-based assays, culture vessels, immunoassays, detection kits for immunohistochemistry (IHC), FPLC columns for protein purification, histological staining reagents, lectins, next-generation sequencing (NGS) products, radiochemicals, plant tissue culture products, and tetramers/monomers for immune cell analysis. The offering represents a unified catalog approach with multiple product sub-categories serving research and diagnostic applications.
Differentiator
Problem solved
Functional benefit
Brands
- upcyte: Upcyte is a product/brand featured on the Clinisciences website related to cell technology.
- ixcyte
- LymphoSign
Products and services
- Immunology, Cell Biology and Molecular Biology Reagents & Instruments Catalog Distributed catalog of reagents, kits, columns, and instruments for immunology, cell biology, and molecular biology research laboratories and diagnostic developers.
- Custom Production of Peptides, Proteins & Antibodies Custom manufacturing service for peptides, proteins, and antibodies tailored to researcher specifications, including GMP-grade options for research and diagnostic applications.
- upcyte Primary Cell Technology Products Proprietary cell expansion products leveraging upcyte technology that generates large quantities of genetically stable primary cells for research and development applications.
- ixCyte Cell Line Development Service Custom cell line development service using the proprietary upcyte platform to generate specialized cell lines for individual researchers and laboratories.
- LymphoSign CE-IVD Diagnostic Workflow CE-IVD classified molecular diagnostic workflow for classifying over 80 subtypes of Non-Hodgkin Lymphoma, intended for clinical and research diagnostic laboratories.
- GMP-Grade Reagent Solutions GMP-grade reagent offerings for research and diagnostic applications where quality, purity, and regulatory compliance are required.
Quantifiable outcome
- Classify over 80 subtypes of Non-Hodgkin Lymphoma using LymphoSign IVD workflow
Companies that use BIOTREND
Customer profileSegments1 record
Ideal customer profiles1 record
BIOTREND technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BIOTREND partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- UpcytecoreUpcyte provides proprietary technology for isolating primary cells from donor tissue and expanding them into error-free proliferating cells. Clinisciences distributes upcyte products and offers ixCyte cell line development services using this technology.
- BiossminorBioss supplies recombinant monoclonal antibodies which Clinisciences distributes and promotes through their platform, including promotional offers such as 30% off electronic pipette smart products.
- LymphoSigncoreLymphoSign provides CE-IVD classified diagnostic workflow capable of classifying over 80 subtypes of Non-Hodgkin Lymphoma. Clinisciences distributes this diagnostic product.
Recent moves5 records
Expansion highlights4 records
BIOTREND competitors and assessment
Company assessmentDirect peers
- GenScript: Custom peptide, protein, and antibody manufacturer with a reagent catalog — directly comparable to BIOTREND/Clinisciences' custom manufacturing service and immunology offerings.
- Tebu-Bio: European-headquartered life-science reagent distributor offering a multi-vendor catalog and custom services across immunology, cell biology, and molecular biology — closest size-and-model comparable.
- Abcam: Specialist antibody and life-science reagent distributor serving research labs globally with a deep catalog and direct e-commerce platform — direct competitor in the antibody/immunoassay segments.
Broad incumbents
- Bio-Rad Laboratories: Established life-science tools and clinical diagnostics company with broad reagent catalog spanning immunoassays, cell biology, and molecular biology — overlapping significantly with Clinisciences' portfolio.
- Thermo Fisher Scientific: Largest global life-science tools and reagents distributor with extensive catalog across immunology, cell biology, and molecular biology, plus custom manufacturing services (e.g., PeproTech). Directly comparable product breadth and customer base.
- Miltenyi Biotec: Major supplier of cell biology reagents, separation technologies, and custom cell services — competes in adjacent cell biology and immunology niches with deep product lines.
- Bio-Techne (R&D Systems): Developer and distributor of high-quality proteins, antibodies, immunoassays, and cell biology reagents — direct competitor across multiple catalog categories and the custom protein services line.
- Merck KGaA (MilliporeSigma): Life-science business of Merck KGaA distributes reagents, antibodies, cell culture products, and molecular biology consumables globally. Competes head-on in the same catalog categories BIOTREND/Clinisciences serves.
Emerging players
- PromoCell: Specialist in primary cells, cell culture media, and cell biology reagents — closely comparable to the upcyte/ixCyte cell biology offering BIOTREND distributes.
- CellGenix: Supplier of GMP-grade cell culture reagents and custom services for cell therapy and regenerative medicine — overlaps with BIOTREND's upcyte/ixCyte cell technology and GMP-grade positioning.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
BIOTREND social profiles
Digital presenceBIOTREND financial estimates
Financial estimateRevenue estimate
Valuation estimate
BIOTREND leadership team
Management profileNumber of profiles
BIOTREND funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BIOTREND M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BIOTREND
What does BIOTREND do?
BIOTREND (operating as Clinisciences) distributes a broad catalog of scientific reagents, kits, and instruments used by research laboratories in immunology, cell biology, and molecular biology. The company also provides custom manufacturing services for peptides, proteins, and antibodies, and distributes proprietary cell technology (upcyte/ixCyte) and CE-IVD diagnostic workflows (LymphoSign). Customers purchase through a B2B e-commerce storefront with account registration and shopping-cart checkout, with international fulfillment via worldwide offices and distributor partners.
Is BIOTREND a public or private company?
BIOTREND is a private company. It is classified as unknown and is currently operating.
When was BIOTREND founded?
BIOTREND was founded in 2002. It employs 1 to 10 people.
Where is BIOTREND based?
BIOTREND is headquartered in Cologne, Germany, in the Europe region.
How does BIOTREND make money?
Two revenue lines are on record. Scientific reagent and instrument sales are the primary driver. The others are custom manufacturing services.
Who are BIOTREND's main competitors?
Direct peers on record are GenScript, Tebu-Bio and Abcam. Broad incumbents are Bio-Rad Laboratories, Thermo Fisher Scientific, Miltenyi Biotec, Bio-Techne (R&D Systems) and Merck KGaA (MilliporeSigma). Emerging players are PromoCell and CellGenix.
Does BIOTREND have an API?
No public API is recorded for BIOTREND.
What industry is BIOTREND in?
BIOTREND's product category is Life Sciences Research Reagents. Its primary akta.pro industry code is CRAFAHAG, Medical, Dental & Lab Supply Marketplaces, with a secondary code of HLAIAJAH, Biologics & Biosimilars Distributors. Its NAICS code is 4242 and its SIC code is 5047.